Accès à distance ? S'identifier sur le proxy UCLouvain
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.
Primary tabs
| Document type | Article de périodique (Journal article) – Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
|---|---|
| Access type | Accès restreint |
| Publication date | 2010 |
| Language | Anglais |
| Journal information | "European Journal of Cancer" - Vol. 46, no. 3, p. 526-33 (2010) |
| Peer reviewed | yes |
| Publisher | Pergamon ((United Kingdom) Kidlington) |
| issn | 0959-8049 |
| e-issn | 1879-0852 |
| Publication status | Publié |
| Affiliations |
UCL
- Service de gastro-entérologie UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie |
| MESH Subject | Adult ; Aged ; Pancreatic Neoplasms - blood, drug therapy ; Quality of Life ; Receptor, Cholecystokinin B - antagonists & inhibitors ; Severity of Illness Index ; Survival Analysis ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage, adverse effects, blood ; Benzodiazepinones - administration & dosage, adverse effects, blood ; Deoxycytidine - administration & dosage, adverse effects, analogs & derivatives, blood ; Female ; Gastrins - blood ; Humans ; Male ; Middle Aged |
| Links |
| Bibliographic reference | Meyer, T ; Caplin, M E ; Palmer, D H ; Valle, J W ; Larvin, M ; et. al. A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.. In: European Journal of Cancer, Vol. 46, no. 3, p. 526-33 (2010) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/95956 |